文献速递湿疹皮炎与荨麻疹

局部浸浴PUVA与窄谱UVB治疗掌部手部湿疹的观察者盲法随机对照预试验

An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema.
PubMed 文献 · Br J Dermatol · 2018-03-14

12周时PUVA组PGA达「清除」或「几乎清除」的ITT应答率为43%,NB-UVB组为23%;两组mTLSS和DLQI均有改善。

要点

  • 局部浸浴PUVA与NB-UVB均能减轻慢性掌部手部湿疹严重度。
  • 12周PGA应答率PUVA组43%、NB-UVB组23%(ITT)。
  • 两组mTLSS与DLQI改善程度相似,安全性和依从性可接受。

核心结论

  • 局部浸浴PUVA和窄谱UVB均能降低慢性掌部手部湿疹的严重度。

研究设计与样本

  • PUVA或NB-UVB每周两次共12周,每4周评估一次。

主要发现

  • PUVA组5例达「清除」、8例达「几乎清除」,ITT应答率43%。
  • NB-UVB组2例达「清除」、5例达「几乎清除」,ITT应答率23%。
  • 两组DLQI变化相似,均有改善。

关键数值与推荐

  • 主要结局为12周PGA达「清除」或「几乎清除」的患者比例。
  • 次要结局包括mTLSS和DLQI。

临床怎么用

  • 对局部强效糖皮质激素无反应的慢性掌部手部湿疹,可考虑局部浸浴PUVA或NB-UVB光疗。
  • 两种光疗方案安全性和依从性可接受,但需注意保留率较低。

局限性

  • 预试验招募困难,随机后保留率较低。
  • 样本量小,每组23例完成12周主要结局评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hand eczema is a common inflammatory dermatosis that causes significant patient morbidity. Previous studies comparing psoralen-ultraviolet A (PUVA) with narrowband ultraviolet B (NB-UVB) have been small, nonrandomized and retrospective. OBJECTIVES: To conduct an observer-blinded randomized controlled pilot study using validated scoring criteria to compare immersion PUVA with NB-UVB for the treatment of chronic hand eczema unresponsive to topical steroids. METHODS: Sixty patients with hand eczema unresponsive to clobetasol propionate 0·05% were randomized to receive either immersion PUVA or NB-UVB twice weekly for 12 weeks with assessments at intervals of 4 weeks. The primary outcome measure was the proportion of patients achieving 'clear' or 'almost clear' Physician's Global Assessment (PGA) response at 12 weeks. Secondary outcome measures included assessment of the modified Total Lesion and Symptom Score (mTLSS) and the Dermatology Life Quality index (DLQI). RESULTS: In both treatment arms, 23 patients completed the 12-week assessment for the primary outcome measure. In the PUVA group, five patients achieved 'clear' and eight 'almost clear' [intention-to-treat (ITT) response rate 43%]. In the NB-UVB group, two achieved 'clear' and five 'almost clear' (ITT response rate 23%). For the secondary outcomes, median mTLSS scores were similar between groups at baseline (PUVA 9·5, NB-UVB 9) and at 12 weeks (PUVA 3, NB-UVB 4). Changes in DLQI were similar, with improvements in both groups. CONCLUSIONS: In this randomized pilot trial recruitment was challenging. After randomization, there were acceptable levels of compliance and safety in each treatment schedule, but lower levels of retention. Using validated scoring systems - PGA, mTLSS and DLQI - as measures of treatment response, the trial demonstrated that both PUVA and NB-UVB reduced the severity of chronic palmar hand eczema.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Brass D, Fouweather T, Stocken DD, et al. An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema. Br J Dermatol. 2018. PMID: 29235664. doi:10.1111/bjd.16238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。